about
Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset ParkinsonismThe modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan AfricaCognitive contributions to gait and falls: evidence and implicationsThe heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients.Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease.A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson DiseaseA neuropsychological longitudinal study in Parkinson's patients with and without hallucinations.Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients.Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients.Resting-state brain networks in patients with Parkinson's disease and impulse control disorders.Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment.Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease.Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease?Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS).Future thinking in Parkinson's disease: an executive function?Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease.Cortical thickness changes in patients with Parkinson's disease and impulse control disorders.Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.Gender and non motor fluctuations in Parkinson's disease: A prospective study.Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.Quitting smoking: an early non-motor feature of Parkinson's disease?Exercise dependence induced by pramipexole in Parkinson's Disease-a case report.Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients.The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy.Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.Pallidal stimulation in atypical pantothenate kinase-associated neurodegeneration: six-year follow-up.Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages.Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release.Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients.Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2.Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease.Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale.Assessment of apathy minimising the effect of motor dysfunctions in Parkinson's disease: a validation study of the dimensional apathy scale.Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients?Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease.Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients.Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease.Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease.
P50
Q28293555-13BA61A5-A059-4F1F-BDEB-C7B0CD38B257Q30586911-C19097A7-8788-414E-997D-74B055915D9FQ33993839-06CB23EF-02F8-4D0C-8F39-2610BF13376BQ34925276-50CF7AB9-F77B-4499-ADFF-665A730FEF70Q35927822-C6B24AC7-2A69-4E0E-839A-DC3382BA67D8Q36460985-831B6F04-64A8-42B6-8FBA-59D912E9D3D3Q38394871-8EFDED48-DC2E-4E58-8973-6B5E1137E58BQ38413789-08046127-E78D-4848-AAEB-EF5D03555BC5Q38465589-91F5469F-8787-44D8-851D-BE4169489EA0Q38675498-2F754C96-71CA-4D05-A0F8-134FC95FF103Q38939751-42D10760-3339-44E3-9F3A-9D047A4DF95FQ38954128-1A5DBE56-FE73-4679-881D-644C932E350DQ39199825-82A5A1BA-631A-470E-94DE-9BCC4035B0AEQ39595469-C1829779-B027-4A07-9C0D-3D63F75AC3B9Q39642545-E25F5741-E394-4E27-92AB-7E31A3DFD5F0Q39784240-91F09CE2-0491-492A-A6AE-12BF5C891C2FQ40061630-610BBF36-9183-4673-B6E2-ED109104C622Q40135189-F3F4095D-E4C8-40A5-9CF5-5DE55F641734Q40806888-39DA428F-17F9-4737-BFEE-9E5BD7592FACQ41439017-A44A4622-4905-4270-9C82-89D97314E151Q41640854-9F8E7971-6B17-4365-B517-61CC1C6C5813Q42945655-30F91B99-8599-4A32-8129-9941B8F3F4B0Q43629565-B052E598-FA8D-4E16-873A-596DB98D2EE4Q43652212-67E3F635-3D27-4FDF-BC47-246F5C0FD118Q43690639-4A62B956-F19B-4705-8C95-4ACB6CE58886Q43906889-2C004672-5E9E-46AD-A292-846A9BFD1FA3Q44950068-A944FAFC-3567-4FA7-87B2-915C7A64872AQ45023745-7E2C1645-896F-4B22-B1FC-89DD76C6F129Q45323520-573A7E59-A1BA-4591-A928-7C20B8A67C2BQ46273692-F43F2E47-8DDD-4B9D-AC7B-B07F69D5CCA3Q46746415-C87BF6DB-BFBB-420B-AB74-0A3C271F5F13Q47734400-07196C24-336F-429F-8E00-342C9F455E43Q47801045-C680BE03-4FE3-4185-AE8A-459D39318D87Q47813794-F7C1DFBA-EE2D-4046-94F8-4B1AC05E38D4Q47921838-38C36E56-7B46-4AA7-BBF0-C5EE10752270Q48113820-D70D4878-6D3D-4169-8A0E-54E5461166C9Q48158470-74DB9939-5441-4EE6-994C-1FA23C982A26Q48259976-3325B504-BD27-4E39-90D3-8CD2CA1379D5Q48300081-8A772615-E6EB-4611-92FE-2C5E30CE97AFQ48320034-68BA7F75-00D6-4393-88FC-1E442275B754
P50
name
Marianna Amboni
@ast
Marianna Amboni
@en
Marianna Amboni
@nl
type
label
Marianna Amboni
@ast
Marianna Amboni
@en
Marianna Amboni
@nl
prefLabel
Marianna Amboni
@ast
Marianna Amboni
@en
Marianna Amboni
@nl